Stockscreener 앱 받기
29.17
0.62%
-0.168
Rapport Therapeutics Inc 주식(RAPP)의 최신 뉴스
TD Asset Management Inc Has $4.07 Million Stock Holdings in Rapport Therapeutics, Inc. $RAPP - MarketBeat
Rapport Therapeutics (RAPP) to Release Quarterly Earnings on Tuesday - MarketBeat
RAPP Should I Buy - Intellectia AI
Liquidity Mapping Around (RAPP) Price Events - Stock Traders Daily
RAPP PE Ratio & Valuation, Is RAPP Overvalued - Intellectia AI
Rapport Therapeutics (NASDAQ:RAPP) Raised to Hold at Wall Street Zen - MarketBeat
Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Unveiling a 73.63% Potential Upside in Biotech Innovation - DirectorsTalk Interviews
Buyout Rumor: What is the cash position of Rapport Therapeutics Inc2025 Macro Impact & Short-Term High Return Ideas - baoquankhu1.vn
Rapport Therapeutics to Participate in Upcoming Investor Conferences - Bitget
Highs Report: What hedge funds are buying Rapport Therapeutics IncGap Down & Consistent Return Investment Signals - baoquankhu1.vn
RAPP Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Rapport Therapeutics, Inc. (RAPP) Investor Outlook: Analyzing A 70.80% Potential Upside - DirectorsTalk Interviews
Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) Insider Sells $246,670.00 in Stock - MarketBeat
Insider Selling: Rapport Therapeutics (NASDAQ:RAPP) CEO Sells 5,833 Shares of Stock - MarketBeat
Why (RAPP) Price Action Is Critical for Tactical Trading - Stock Traders Daily
RAPP Stock Price and Chart — NASDAQ:RAPP - TradingView
We're Not Very Worried About Rapport Therapeutics' (NASDAQ:RAPP) Cash Burn Rate - Yahoo Finance
Can Rapport Therapeutics Inc. stock deliver surprise earnings beatMarket Sentiment Review & Weekly High Momentum Picks - mfd.ru
RAPP Technical Analysis & Stock Price Forecast - Intellectia AI
Rapport Therapeutics, Inc. (RAPP) Stock Analysis: A Deep Dive Into Its 83% Potential Upside - DirectorsTalk Interviews
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Does Rapport Therapeutics Inc. have strong fundamentals2025 Price Action Summary & Technical Pattern Based Signals - mfd.ru
Will Rapport Therapeutics Inc. stock split again soonInsider Selling & Precise Trade Entry Recommendations - mfd.ru
Understanding Momentum Shifts in (RAPP) - Stock Traders Daily
RSI Check: What hedge funds are buying Rapport Therapeutics IncM&A Rumor & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
A Look At Rapport Therapeutics (RAPP) Valuation After Fresh Overweight Rating From Wells Fargo - Sahm
Rapport Therapeutics (NASDAQ:RAPP) Stock Rating Lowered by Wall Street Zen - MarketBeat
Rapport Therapeutics, Inc. (RAPP) Investor Outlook: A 100% Upside Potential In Biotech Sector - DirectorsTalk Interviews
Rapport Therapeutics Completes Key Phase 2a Epilepsy Study for RAP-219: What Investors Should Watch Next - TipRanks
Rapport Therapeutics (NASDAQ:RAPP) Now Covered by Analysts at Wells Fargo & Company - Defense World
Wells Fargo Initiates Coverage of Rapport Therapeutics (RAPP) with Overweight Recommendation - Nasdaq
Rapport Therapeutics (RAPP): Analyst Initiates Coverage with Ove - GuruFocus
Wells Fargo Initiates Coverage on Rapport Therapeutics With Overweight Rating, $43 Price Target - marketscreener.com
Wells Fargo & Company Begins Coverage on Rapport Therapeutics (NASDAQ:RAPP) - MarketBeat
Aug Final Week: What are Rapport Therapeutics Inc.’s technical support levels2025 Market WrapUp & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Whale Trades: What is the dividend yield of PMGC Holdings IncWeekly Trading Summary & Fast Gain Swing Alerts - baoquankhu1.vn
Aug Breakouts: Why is Rapport Therapeutics Inc stock going upStock Surge & Accurate Intraday Trading Signals - baoquankhu1.vn
Activity Recap: What hedge funds are buying Rapport Therapeutics IncJuly 2025 PreEarnings & Free Long-Term Investment Growth Plans - baoquankhu1.vn
Rapport Therapeutics, Inc. (RAPP) Stock Analysis: Promising Biotech with Nearly 95% Upside Potential - DirectorsTalk Interviews
Will Rapport Therapeutics Inc. stock gain from strong economyMarket Trend Review & Verified Stock Trade Ideas - mfd.ru
Should I buy Rapport Therapeutics Inc. stock nowCEO Change & Intraday High Probability Setup Alerts - mfd.ru
Is Rapport Therapeutics Inc. undervalued by DCF analysis2025 Fundamental Recap & Intraday High Probability Setup Alerts - mfd.ru
Layoff Watch: Is Rapport Therapeutics Inc gaining market shareQuarterly Portfolio Summary & Free Community Supported Trade Ideas - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (RAPP) Movement - Stock Traders Daily
Retail Surge: Is Rapport Therapeutics Inc gaining market shareWeekly Stock Summary & Expert Approved Trade Ideas - baoquankhu1.vn
Rapport Therapeutics (NASDAQ:RAPP) Upgraded to Hold at Wall Street Zen - MarketBeat
JonesTrading Maintains Rapport Therapeutics(RAPP.US) With Buy Rating, Maintains Target Price $50 - 富途牛牛
Rapport Therapeutics, Inc. (RAPP): Investor Outlook With An 87% Potential Upside - DirectorsTalk Interviews
Rapport Therapeutics CEO Ceesay sells $285k in shares By Investing.com - Investing.com Australia
Abraham Ceesay Sells 5,833 Shares of Rapport Therapeutics (NASDAQ:RAPP) Stock - MarketBeat
Rapport Therapeutics CEO Ceesay sells $285k in shares - Investing.com
Short Interest in Rapport Therapeutics, Inc. (NASDAQ:RAPP) Expands By 20.7% - Defense World
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Short Interest Up 20.7% in December - MarketBeat
Rapport Therapeutics, Inc. (NASDAQ:RAPP) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
0.50%
자본화:
|
볼륨(24시간):